Recent Price Movement and Market Context
Fredun Pharmaceuticals has demonstrated remarkable resilience and growth over the past year, with a one-year return of 133.9%, significantly outperforming the Sensex’s modest 3.6% gain during the same period. Year-to-date, the stock has surged by 136.5%, dwarfing the benchmark’s 8.4% rise. Even over a five-year horizon, Fredun’s returns of 476.3% far exceed the Sensex’s 81.5%, underscoring its strong long-term performance within the pharmaceutical sector.
Despite a slight one-month dip of 2.5%, the stock’s weekly performance remains positive at +0.3%, marginally ahead of the Sensex’s 0.02% gain. This recent uptick suggests renewed investor confidence after a brief consolidation phase.
Technical Factors Supporting ...
Read More













